Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 1
2006 3
2007 3
2008 6
2009 4
2010 1
2011 9
2012 7
2013 9
2014 6
2015 8
2016 8
2017 15
2018 23
2019 23
2020 22
2021 25
2022 42
2023 42
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for huijuan yang
Search for Haiguan Yang instead (3 results)
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Shi T, Zhu J, Feng Y, Tu D, Zhang Y, Zhang P, Jia H, Huang X, Cai Y, Yin S, Jiang R, Tian W, Gao W, Liu J, Yang H, Cheng X, Zang R. Shi T, et al. Among authors: yang h. Lancet Oncol. 2021 Apr;22(4):439-449. doi: 10.1016/S1470-2045(21)00006-1. Epub 2021 Mar 8. Lancet Oncol. 2021. PMID: 33705695 Clinical Trial.
Real-world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non-interventional study in China.
Li J, Yang J, Shou H, Zhang L, Huang X, Tang X, Zheng F, Liu F, Wen H, Yang H, Wang H, Li Z, Chen X, Ju X, Cheng X, Tang J, Zhang M, Wu X. Li J, et al. Among authors: yang h. Cancer Commun (Lond). 2023 Jun;43(6):716-719. doi: 10.1002/cac2.12418. Epub 2023 Apr 11. Cancer Commun (Lond). 2023. PMID: 37040265 Free PMC article. No abstract available.
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40.
Yang F, He Z, Duan H, Zhang D, Li J, Yang H, Dorsey JF, Zou W, Nabavizadeh SA, Bagley SJ, Abdullah K, Brem S, Zhang L, Xu X, Byrne KT, Vonderheide RH, Gong Y, Fan Y. Yang F, et al. Among authors: yang h. Nat Commun. 2021 Jun 8;12(1):3424. doi: 10.1038/s41467-021-23832-3. Nat Commun. 2021. PMID: 34103524 Free PMC article.
236 results